Our findings encourage a thoughtful reconsideration of their role since we documented that FLT3, KRAS and NRAS mutations are also a common event in B-NEG ALL with a different distribution across age cohorts. The gene discussed is FLT3; the disease is acute lymphoblastic leukemia.